Drugs / TTK
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00632333 | Feb 2008 → Dec 2011 | esophageal cancer | Teikyo University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00632333 ↗ |
| Target | TTK | “Up-regulated ling cancer 10 (URLC10), TTK protein kinase (TTK) and K homology domain containing protein over expressed in cancer (KOC1) were identified as new targets of tumor...” NCT00632333 ↗ |